← Back to Conditions

Xeroderma pigmentosum, group B

disorder
SNOMED 1073003CUI C0268136

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Abnormal CNS myelination
HP:0011400
Abnormally small eyeball
HP:0000568
Ataxia
HP:0001251
Basal cell nevus
HP:0002671
Basal ganglion calcification
HP:0002135
Cancer
HP:0002664
Cataract
HP:0000518
Cutaneous melanoma
HP:0012056
Cutaneous photosensitivity
HP:0000992
Decreased activity of gonads
HP:0000135
Decreased body height
HP:0004322
Decreased nerve conduction velocity
HP:0000762
Decreased size of cranium
HP:0000252
Dilated cerebral ventricle
HP:0002119
Freckling
HP:0001480
Increased cellular sensitivity to UV light
HP:0003224
Increased reflexes
HP:0001347
Infratentorial atrophy
HP:0001272
Nonprogressive mental retardation
HP:0001249
Optic atrophy
HP:0000648
Pigmentary retinal deposits
HP:0000580
Progeroid facial appearance
HP:0005328
Sensorineural deafness
HP:0000407
Skin degeneration
HP:0004334
Squamous skin carcinoma
HP:0006739

Quick Facts

SNOMED CT
1073003
UMLS CUI
C0268136
Fully Specified Name
Xeroderma pigmentosum, group B (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
25
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.